These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 18156531

  • 1. Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment?
    Tomlinson DR, Cherian P, Betts TR, Bashir Y.
    Emerg Med J; 2008 Jan; 25(1):15-8. PubMed ID: 18156531
    [Abstract] [Full Text] [Related]

  • 2. Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison.
    Marill KA, deSouza IS, Nishijima DK, Senecal EL, Setnik GS, Stair TO, Ruskin JN, Ellinor PT.
    Acad Emerg Med; 2010 Mar; 17(3):297-306. PubMed ID: 20370763
    [Abstract] [Full Text] [Related]

  • 3. Amiodarone is poorly effective for the acute termination of ventricular tachycardia.
    Marill KA, deSouza IS, Nishijima DK, Stair TO, Setnik GS, Ruskin JN.
    Ann Emerg Med; 2006 Mar; 47(3):217-24. PubMed ID: 16492484
    [Abstract] [Full Text] [Related]

  • 4. Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
    Long B, Koyfman A.
    J Emerg Med; 2017 Apr; 52(4):484-492. PubMed ID: 27751700
    [Abstract] [Full Text] [Related]

  • 5. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study.
    Ortiz M, Martín A, Arribas F, Coll-Vinent B, Del Arco C, Peinado R, Almendral J, PROCAMIO Study Investigators.
    Eur Heart J; 2017 May 01; 38(17):1329-1335. PubMed ID: 27354046
    [Abstract] [Full Text] [Related]

  • 6. Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone.
    Somberg JC, Timar S, Bailin SJ, Lakatos F, Haffajee CI, Tarjan J, Paladino WP, Sarosi I, Kerin NZ, Borbola J, Bridges DE, Molnar J, Amio-Aqueous Investigators.
    Am J Cardiol; 2004 Mar 01; 93(5):576-81. PubMed ID: 14996582
    [Abstract] [Full Text] [Related]

  • 7. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J, Hidden F, Naditch L, Coutte R, Himbert C, Frank R.
    Ann Cardiol Angeiol (Paris); 1996 Jan 01; 45(1):18-23. PubMed ID: 8815771
    [Abstract] [Full Text] [Related]

  • 8. Amiodarone in the new AHA guidelines for ventricular tachyarrhythmias.
    Caron MF, Kluger J, White CM.
    Ann Pharmacother; 2001 Oct 01; 35(10):1248-54. PubMed ID: 11675855
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Control of tachycardia with intravenous amiodarone in acute left heart failure].
    Tomcsányi J, Arabadzisz H, Zsoldos A, Marosi A, Beck K.
    Orv Hetil; 2001 Dec 30; 142(52):2899-901. PubMed ID: 11828940
    [Abstract] [Full Text] [Related]

  • 11. Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias.
    Rea RS, Kane-Gill SL, Rudis MI, Seybert AL, Oyen LJ, Ou NN, Stauss JL, Kirisci L, Idrees U, Henderson SO.
    Crit Care Med; 2006 Jun 30; 34(6):1617-23. PubMed ID: 16614583
    [Abstract] [Full Text] [Related]

  • 12. Comparative study of intravenous amiodarone and procainamide in the treatment of atrial fibrillation of recent onset.
    Xanthos T, Prapa V, Papadimitriou D, Papadimitriou L.
    Minerva Cardioangiol; 2007 Aug 30; 55(4):433-41. PubMed ID: 17653020
    [Abstract] [Full Text] [Related]

  • 13. Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction.
    Kułakowski P, Karczmarewicz S, Karpiński G, Soszyńska M, Ceremuzyński L.
    Europace; 2000 Jul 30; 2(3):207-15. PubMed ID: 11227590
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia.
    Somberg JC, Bailin SJ, Haffajee CI, Paladino WP, Kerin NZ, Bridges D, Timar S, Molnar J, Amio-Aqueous Investigators.
    Am J Cardiol; 2002 Oct 15; 90(8):853-9. PubMed ID: 12372573
    [Abstract] [Full Text] [Related]

  • 17. Safety and tolerability of intravenous cibenzoline for acute termination of spontaneous sustained ventricular tachycardia. Cibenzoline and spontaneous VT.
    Chevalier P, Dacosta A, Chalvidan T, Bonnefoy E, Kirkorian G, Isaaz K, Touboul P.
    Int J Cardiol; 1998 May 15; 64(3):265-70. PubMed ID: 9672407
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of combination therapy with amiodarone and type I agents for treatment of inducible ventricular tachycardia.
    Jung W, Mletzko R, Manz M, Nitsch J, Lüderitz B.
    Pacing Clin Electrophysiol; 1993 Apr 15; 16(4 Pt 1):778-88. PubMed ID: 7683805
    [Abstract] [Full Text] [Related]

  • 19. An overview of antiarrhythmic drug management of electrical storm.
    Kowey PR.
    Can J Cardiol; 1996 Apr 15; 12 Suppl B():3B-8B; discussion 27B-28B. PubMed ID: 8616726
    [Abstract] [Full Text] [Related]

  • 20. Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate.
    Hofmann R, Steinwender C, Kammler J, Kypta A, Leisch F.
    Int J Cardiol; 2006 Jun 07; 110(1):27-32. PubMed ID: 16046015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.